{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:01:42Z","timestamp":1792152102645,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.kint.2022.09.027","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T18:55:55Z","timestamp":1666896955000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis"],"prefix":"10.1016","volume":"103","author":[{"given":"Thibaud","family":"Chazal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Manari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charlotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roei D.","family":"Mazor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaele","family":"Renard-Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cohen-Aubart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Izzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2022.09.027_bib1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood.2019002766","article-title":"Erdheim-Chester disease","volume":"135","author":"Haroche","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib3","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41375-020-0944-4","article-title":"Erdheim-Chester disease: a rapidly evolving disease model","volume":"34","author":"Pegoraro","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.kint.2022.09.027_bib4","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood.2019003507","article-title":"Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era","volume":"135","author":"Goyal","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib5","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1002\/ajh.25055","article-title":"Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort","volume":"93","author":"Cohen-Aubart","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2022.09.027_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.kint.2022.09.027_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.urology.2013.10.023","article-title":"Urologic manifestations of Erdheim-Chester disease","volume":"84","author":"Yelfimov","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.kint.2022.09.027_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10157-012-0675-6","article-title":"Image of Erdheim-Chester disease requiring hemodialysis","volume":"16","author":"Tsukamoto","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2022.09.027_bib9","article-title":"Kidney transplantation for Erdheim-Chester disease","volume":"2020","author":"Yoo","year":"2020","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.kint.2022.09.027_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","article-title":"Treatment of Erdheim-Chester disease with long-term high-dose interferon-\u03b1","volume":"41","author":"Hervier","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.kint.2022.09.027_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib12","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1182\/blood-2016-07-724815","article-title":"Cardiac involvement in Erdheim-Chester disease: an MRI study","volume":"128","author":"Gianfreda","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010748","article-title":"Central nervous system involvement in Erdheim-Chester disease: an observational cohort study","volume":"95","author":"Cohen Aubart","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.kint.2022.09.027_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013452","article-title":"Arterial involvement in Erdheim\u2013Chester disease: a retrospective cohort study","volume":"97","author":"Villatoro-Villar","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.kint.2022.09.027_bib15","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1002\/art.27672","article-title":"Pulmonary involvement in Erdheim\u2013Chester disease: a single-center study of thirty-four patients and a review of the literature","volume":"62","author":"Arnaud","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2022.09.027_bib16","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"suppl 1","key":"10.1016\/j.kint.2022.09.027_bib18","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.kint.2022.09.027_bib19","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2022.09.027_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5527\/wjn.v5.i2.172","article-title":"Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction","volume":"5","author":"Hsu","year":"2016","journal-title":"World J Nephrol"},{"key":"10.1016\/j.kint.2022.09.027_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/iju.14235","article-title":"Management and treatment options when facing malignant ureteral obstruction","volume":"27","author":"Tabib","year":"2020","journal-title":"Int J Urol"},{"key":"10.1016\/j.kint.2022.09.027_bib22","doi-asserted-by":"crossref","first-page":"e3625","DOI":"10.1097\/MD.0000000000003625","article-title":"Erdheim\u2013Chester disease as a mimic of IgG4-related disease: a case report and a review of a single-center cohort","volume":"95","author":"Gianfreda","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.kint.2022.09.027_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fimmu.2019.00693","article-title":"Clinical and prognostic significance of serum IgG4 in chronic periaortitis: an analysis of 113 patients","volume":"10","author":"Maritati","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2022.09.027_bib24","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1007\/s00330-018-5326-1","article-title":"Abdominal involvement in Erdheim\u2013Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation","volume":"28","author":"Nikpanah","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.kint.2022.09.027_bib25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2017-07-795054","article-title":"Erdheim-Chester disease: the \"targeted\" revolution","volume":"130","author":"Vaglio","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.09.027_bib27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2017-03-771873","article-title":"Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)","volume":"130","author":"Cohen Aubart","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib28","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.2019004478","article-title":"Long-term follow-up of mTOR inhibition for Erdheim-Chester disease","volume":"135","author":"Pegoraro","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.09.027_bib29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaoncol.2015.1713","article-title":"Nephrotoxicity of the BRAF inhibitors vemurafenib and dabrafenib","volume":"1","author":"Jhaveri","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.kint.2022.09.027_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2016-12-757823","article-title":"Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults","volume":"130","author":"Milne","year":"2017","journal-title":"Blood"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253822009073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253822009073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:03:54Z","timestamp":1758762234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253822009073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0085253822009073"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2022.09.027","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2022.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}